Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes
- PMID: 35733233
- DOI: 10.1111/jsap.13525
Lymphadenectomy improves outcome in dogs with resected Kiupel high-grade cutaneous mast cell tumours and overtly metastatic regional lymph nodes
Abstract
Introduction: Historically, the prognosis for dogs with stage II Kiupel high-grade cutaneous mast cell tumours has been considered poor.
Objectives: The aim of this study was to explore the impact of lymphadenectomy on outcome in dogs with Kiupel high-grade cutaneous mast cell tumours and overt regional lymph node metastasis.
Material and methods: Data from dogs with completely staged Kiupel high-grade cutaneous mast cell tumours with overt and/or certain regional lymph node metastasis undergoing excision of the primary tumours and adjuvant medical treatment were extracted. Dogs with a cytological diagnosis of regional lymph node metastasis that did not undergo lymphadenectomy were compared with dogs that underwent lymphadenectomy and had a histological diagnosis of overt lymph node metastasis.
Results: Forty-nine dogs were included, 18 did not undergo lymphadenectomy while 31 underwent lymphadenectomy. Median time to progression was significantly shorter in dogs that did not undergo lymphadenectomy (150 days, 95% confidence interval: 129 to 170) compared to the other dogs (229 days, 95% confidence interval: 191 to 266). Median survival time was also shorter in dogs that did not undergo lymphadenectomy (250 days, 95% confidence interval: 191 to 308) compared to dogs that underwent lymphadenectomy (371 days, 95% confidence interval: 311 to 430). On multivariable analysis, lack of lymphadenectomy was associated with higher risk of overall tumour progression (hazard ratio: 2.05, 95% confidence interval: 1.02 to 4.13), nodal progression (hazard ratio: 3.4, 95% confidence interval: 1.65 to 7.02) and tumour-related death (hazard ratio 3.63, 95% confidence interval: 1.72 to 7.66), whereas tumour size was associated with higher risk of local recurrence (hazard ratio: 3.61, 95% confidence interval: 1.06 to 13).
Clinical significance: Regional lymphadenectomy may improve outcome in dogs with biologically aggressive cutaneous mast cell tumours.
© 2022 British Small Animal Veterinary Association.
References
-
- Baginski, H., Davis, G. & Bastian, R. P. (2014) The prognostic value of lymph node metastasis with grade 2 MCTs in dogs: 55 cases (2001-2010). Journal of the American Animal Hospital Association 50, 89-95
-
- Blackwood, L., Murphy, S., Buracco, P., et al. (2012) European consensus document on mast cell tumours in dogs and cats. Veterinary and Comparative Oncology 10, 1-29
-
- Dobson, M. J. & Scase, J. T. (2007) Advance in the diagnosis and management of cutaneous mast cell tumours in dogs. The Journal of Small Animal Practice 48, 424-431
-
- Donnelly, L., Mulin, C., Balko, J., et al. (2015) Evaluation of histological grade and histologically tumor-free margins as predictors of local recurrence in completely excised canine mast cell tumors. Veterinary and Comparative Oncology 13, 70-76
-
- Dores, B. C., Milovancev, M. & Russel, S. D. (2017) Comparison of histologic margin status in low-grade cutaneous and subcutaneous mast cell tumours examined by radial and tangential sections. Veterinary and Comparative Oncology 16, 125-130
MeSH terms
LinkOut - more resources
Full Text Sources
